Table 3 Severity of the Complications
Reference (year) | Severity | n (%) | P | |
|---|---|---|---|---|
LMLR | OMLR | |||
Cho JY (2015) [23] | NA | NA | NA | NA |
Xiao L (2015) [24] | ≤II | 5 (12.2%) | 25 (29.1%) | 0.036 |
≥III | 2 (4.9%) | 7 (8.1%) | 0.764 | |
Komatsu S (2016) [25] | ≤II | 7 (18.4%) | 16 (42.1%) | 0.023 |
≥III | 5 (13.2%) | 7 (18.4) | 0.529 | |
Zhang Y (2016) [26] | I | 20 (100%) | 15 (60%) | < 0.05 |
II | 0 (0) | 8 (32%) | < 0.05 | |
III | 0 (0) | 2 (8%) | < 0.05 | |
Chen JH (2017) [27] | II | 14 (11.1%) | 24 (18.0%) | 0.115 |
III | 0 (0) | 4 (3.0%) | 0.123 | |
IV | 2 (1.6%) | 4 (3.0%) | 0.685 | |
Yoon YI (2017) [28] | NA | NA | NA | NA |
Guro H (2018) [29] | ≤II | 10 () | 16 () | 0.029 |
≥III | 7 () | 27 () | ||
Rhu J (2018) [30] | ≤II | 4 (6.9%) | 9 (6.8%) | 0.528 |
≥III | 1 (1.7%) | 2 (1.5%) | ||
Xu H (2018) [31] | ≤II | 11 (30.6%) | 24 (35.8%) | 0.024 |
≥III | 0 (0) | 12 (17.9%) | 0.017 | |